Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Artemis Therapeutics Inc (PK) | ATMS | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.498 | 0.498 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.1121 - 1.89 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.498 | USD |
Artemis Therapeutics Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 55.79M | 112.03M | 12.88M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Artemis Therapeutics (PK) News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATMS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.60 | 1.89 | 0.1121 | 0.4605747 | 2,708 | -0.102 | -17.00% |
3 Years | 0.3162 | 7.02 | 0.1121 | 1.97 | 3,857 | 0.1818 | 57.50% |
5 Years | 0.2601 | 7.02 | 0.032 | 1.01 | 5,706 | 0.2379 | 91.46% |
Artemis Therapeutics (PK) Description
Manuka's business activities primarily consist of developing and manufacturing skincare products based on New Zealand's Manuka honey and bee venom, among other natural ingredients. Manuka is also distributing Manuka honey to consumers. All of Manuka's products are marketed and sold on the internet. Manuka's skincare products are manufactured in Israel. Manuka plans to distribute its products in the U.S. market, based on permits granted by the U.S. Food and Drug Administration. |